Purpose: In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin were investigated by studying time-kill kinetics and post-antibiotic effect (PAE) against strains of Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Method: Synergy was investigated at 0.5x, 1x and 5x MIC of antibiotics using time-kill curve method. PAEs were determined by the standard viable counting method where bacteria in the logarithmic phase of growth were exposed for 1 h to the antibiotics at 1x or 20x MIC, alone and in combinations. Synergy and additive effects were detected at 1xMIC, at 24 h. Results: Some of the strains produced an earlier synergistic effect at 12 h. No antagonism was observed. Colistin methanesulfonate and a...
Background: Resistance to colistin is emerging in multidrug-resistant Gram-negative bacteria and no ...
Resistant bacteria are becoming more and more of a problem but treatment with antibiotics in combina...
The aim of the study was to assess the microbiological activity and clinical efficacy of colistin an...
Purpose: In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin were investig...
The in vitro pharmacodynamic properties of colistin and colistin methanesulfonate were investigated ...
Copyright © The Author 2008. Published by Oxford University Press on behalf of the British Society f...
Background: In view of the paucity of clinical evidence, in vitro studies are needed to find antibio...
ObjectiveTo study the interactions of colistin (MIC 2 mg/L) at concentrations of 0.5 and 5 mg/L with...
Objectives: The potential for synergy between colistin and fusidic acid in the treatment of MDR Acin...
The use of colistin, a 50-year old polymyxin antibiotic with a reportedly high incidence of nephroto...
OBJECTIVES: Combination therapy is recommended for the treatment of KPC-producing Klebsiella pneumo...
The time course of activity of colistin and imipenem against mucoid and nonmucoid Pseudomonas aerugi...
Objectives: Colistin is an old drug, which is being increasingly utilized due to limited therapeutic...
Colistin is increasingly used as last-line therapy against Gram-negative pathogens. The pharmacokine...
Colistin is increasingly used as last-line therapy against Gram-negative pathogens. The pharmacokine...
Background: Resistance to colistin is emerging in multidrug-resistant Gram-negative bacteria and no ...
Resistant bacteria are becoming more and more of a problem but treatment with antibiotics in combina...
The aim of the study was to assess the microbiological activity and clinical efficacy of colistin an...
Purpose: In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin were investig...
The in vitro pharmacodynamic properties of colistin and colistin methanesulfonate were investigated ...
Copyright © The Author 2008. Published by Oxford University Press on behalf of the British Society f...
Background: In view of the paucity of clinical evidence, in vitro studies are needed to find antibio...
ObjectiveTo study the interactions of colistin (MIC 2 mg/L) at concentrations of 0.5 and 5 mg/L with...
Objectives: The potential for synergy between colistin and fusidic acid in the treatment of MDR Acin...
The use of colistin, a 50-year old polymyxin antibiotic with a reportedly high incidence of nephroto...
OBJECTIVES: Combination therapy is recommended for the treatment of KPC-producing Klebsiella pneumo...
The time course of activity of colistin and imipenem against mucoid and nonmucoid Pseudomonas aerugi...
Objectives: Colistin is an old drug, which is being increasingly utilized due to limited therapeutic...
Colistin is increasingly used as last-line therapy against Gram-negative pathogens. The pharmacokine...
Colistin is increasingly used as last-line therapy against Gram-negative pathogens. The pharmacokine...
Background: Resistance to colistin is emerging in multidrug-resistant Gram-negative bacteria and no ...
Resistant bacteria are becoming more and more of a problem but treatment with antibiotics in combina...
The aim of the study was to assess the microbiological activity and clinical efficacy of colistin an...